Oruka Therapeutics (ORKA) Change in Taxes (2018 - 2019)
Oruka Therapeutics' quarterly Change in Taxes came in at $16000.0 in Q4 2019, down 30.43% year-on-year from $23000.0 in Q4 2018, and down 61.9% quarter-over-quarter from $42000.0 in Q3 2019.
Oruka Therapeutics has reported Change in Taxes for 2 years, with the latest figure at $16000.0 in Q4 2019.
- For the quarter ending Q4 2019, Change in Taxes fell 30.43% year-over-year to $16000.0; the trailing twelve-month figure through Dec 2020 stood at $58000.0 (down 65.27% YoY), and the FY2020 full-year result was $9000.0, down 94.61% from the prior year.
- Change in Taxes for Q4 2019 stood at $16000.0, down from $42000.0 in the prior quarter.
- The five-year high for Change in Taxes was $82000.0 in Q1 2019, with the low at $16000.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 16,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Jun 30, 2019 | 27,000.00 |
| Jun 30, 2019 | 27,000.00 |
| Mar 31, 2019 | 82,000.00 |
| Mar 31, 2019 | 82,000.00 |
| Dec 31, 2018 | 23,000.00 |
| Dec 31, 2018 | 23,000.00 |